Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia. [electronic resource]
Producer: 20031128Description: 105-10 p. digitalISSN:- 1526-9655
- Adult
- Aged
- Aged, 80 and over
- Alemtuzumab
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- adverse effects
- Cytomegalovirus Infections -- complications
- Fever
- Ganciclovir -- therapeutic use
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Leukemia, Prolymphocytic -- drug therapy
- Middle Aged
- Neutrophils -- drug effects
- Polymerase Chain Reaction
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.